The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
Condition: Prostate Cancer Interventions: Drug: (64Cu)-labeled PSMA-targeting particle tracer, or 64Cu-NOTA-PSMAi-PEG-Cy5.5-C' dots; Diagnostic Test: PET/MRI; Other: Blood and urine sampling; Procedure: laparoscopic radical prostatectomy and bilateral pelvic LN dissection Sponsors: Memorial Sloan Kettering Cancer Center; Elucida Oncology; National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Laparoscopy | Nanotechnology | Prostate Cancer | Prostatectomy | Research